Literature DB >> 8617867

Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.

M G Netea1, P N Demacker, B J Kullberg, O C Boerman, I Verschueren, A F Stalenhoef, J W van der Meer.   

Abstract

Lipoproteins can bind lipopolysaccharide (LPS) and decrease the LPS-stimulated production of pro-inflammatory cytokines. We investigated the effect of increased plasma concentrations of low-density-lipoproteins (LDL) on survival and cytokine production after a lethal challenge with either LPS or live Gram-negative bacteria in LDL receptor deficient mice (LDLR-/-). The LDLR-/- mice challenged with LPS had an eightfold increased LD50 when compared with the wild type controls (C57Bl/6J), while tumor necrosis factor alpha (TNFalpha) and interleukin-1 alpha (IL-1 alpha) plasma concentrations were decreased twofold. LDLR-/- mice had significantly lower and delayed mortality than control mice after infection with Klebsiella pneumoniae. No differences in the outgrowth of bacteria in the organs were present between the two groups, while circulating cytokine concentrations were decreased twofold in LDLR-/- mice. In contrast, the LPS-stimulated in vitro production of cytokines by peritoneal macrophages of LDLR-/- mice was significantly increased compared with controls. This increase was associated with enhanced specific binding of LPS to the macrophages of LDLR-/- mice. In conclusion, endogenous LDL can protect against the lethal effects of endotoxin and Gram-negative infection. At least part of this protection is achieved through decreased in vivo production of pro-inflammatory cytokines, in spite of increased cytokine production capacity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617867      PMCID: PMC507194          DOI: 10.1172/JCI118556

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Genetic control of responses to bacterial lipopolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipipolysaccharides.

Authors:  J Watson; R Riblet
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

2.  Chylomicrons can inhibit endotoxin activity in vitro.

Authors:  E B Eichbaum; H W Harris; J P Kane; J H Rapp
Journal:  J Surg Res       Date:  1991-11       Impact factor: 2.192

3.  Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.

Authors:  M M Wurfel; E Hailman; S D Wright
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

4.  Role for circulating lipoproteins in protection from endotoxin toxicity.

Authors:  K R Feingold; J L Funk; A H Moser; J K Shigenaga; J H Rapp; C Grunfeld
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

Review 5.  Adjunctive therapy for septic shock: a review of experimental approaches.

Authors:  W A Lynn; J Cohen
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

6.  Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice.

Authors:  M G Netea; W L Blok; B J Kullberg; M Bemelmans; M T Vogels; W A Buurman; J W van der Meer
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

7.  In vivo protection against endotoxin by plasma high density lipoprotein.

Authors:  D M Levine; T S Parker; T M Donnelly; A Walsh; A L Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection.

Authors:  M T Vogels; E J Mensink; K Ye; O C Boerman; C M Verschueren; C A Dinarello; J W van der Meer
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

9.  LPS-induced release of IL-1 beta, IL-6, IL-8, TNF-alpha and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein.

Authors:  J B Eggesbø; I Hjermann; P K Lund; G B Joø; R Ovstebø; P Kierulf
Journal:  Cytokine       Date:  1994-09       Impact factor: 3.861

10.  Triglyceride-rich lipoproteins prevent septic death in rats.

Authors:  T E Read; C Grunfeld; Z L Kumwenda; M C Calhoun; J P Kane; K R Feingold; J H Rapp
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

View more
  51 in total

1.  Hypercholesterolemic LDL receptor-deficient mice mount a neutrophilic response to tuberculosis despite the timely expression of protective immunity.

Authors:  Gregory W Martens; Therese Vallerskog; Hardy Kornfeld
Journal:  J Leukoc Biol       Date:  2012-01-06       Impact factor: 4.962

2.  Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism.

Authors:  Marije Oosting; Frank L van de Veerdonk; Thirumala-Devi Kanneganti; Patrick Sturm; Ineke Verschueren; Anneleen Berende; Jos W M van der Meer; Bart-Jan Kullberg; Mihai G Netea; Leo A B Joosten
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

3.  Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix.

Authors:  Jimmy F P Berbée; Claudia P Coomans; Marit Westerterp; Johannes A Romijn; Louis M Havekes; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2010-03-24       Impact factor: 5.922

4.  Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study.

Authors:  E J Sijbrands; R G Westendorp; J C Defesche; P H de Meier; A H Smelt; J J Kastelein
Journal:  BMJ       Date:  2001-04-28

5.  Is hypercholesterolemia a friend or a foe of tuberculosis?

Authors:  Runlin Han; Hardy Kornfeld; Gregory Martens
Journal:  Infect Immun       Date:  2009-08       Impact factor: 3.441

6.  More than inflammation: interleukin-1beta polymorphisms and the lipid metabolism.

Authors:  Mihai G Netea; Charles A Dinarello
Journal:  J Clin Endocrinol Metab       Date:  2011-05       Impact factor: 5.958

7.  Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load.

Authors:  J Ghosh; C S Lal; K Pandey; V N R Das; P Das; K Roychoudhury; S Roy
Journal:  Ann Trop Med Parasitol       Date:  2011-04

8.  Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction.

Authors:  D D Bannerman; M J Fitzpatrick; D Y Anderson; A K Bhattacharjee; T J Novitsky; J D Hasday; A S Cross; S E Goldblum
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

9.  Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes.

Authors:  Johanneke Kleinnijenhuis; Jessica Quintin; Frank Preijers; Leo A B Joosten; Daniela C Ifrim; Sadia Saeed; Cor Jacobs; Joke van Loenhout; Dirk de Jong; Hendrik G Stunnenberg; Ramnik J Xavier; Jos W M van der Meer; Reinout van Crevel; Mihai G Netea
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

10.  Increased interleukin-1alpha and interleukin-1beta production by macrophages of low-density lipoprotein receptor knock-out mice stimulated with lipopolysaccharide is CD11c/CD18-receptor mediated.

Authors:  M G Netea; P N Demacker; B J Kullberg; O C Boerman; I Verschueren; A F Stalenhoef; J W Van Der Meer
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.